Prem Shankar Patel

Dr. Prem Shankar Patel


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SSShivendra Singh
Shivendra Singh
PPPrem Shankar Patel
Prem Shankar Patel
AAArchana Archana
Archana Archana
The heterogeneous spectrum of kidney disease in diabetes ranges from albuminuric or non-albuminuric diabetic kidney disease to non-diabetic kidney diseases. Presumptive clinical diagnosis of diabetic kidney disease may lead to an erroneous diagnosis. Material and Method: We analyzed the clinical profile and kidney biopsy of a total of 66 type 2 diabetes patients. Based on kidney histology, they were divided into—Class I (Diabetic Nephropathy), Class II (Non-diabetic kidney disease), and Class III (Mixed lesion). Demographic data, clinical presentation, and laboratory values were collected and analyzed. This study tried to examine the heterogeneity in kidney disease, its clinical indicator, and the role of kidney biopsy in the diagnosis of kidney disease in diabetes. Results: Class I consisted of 36(54.5%), class II 17(25.8%), and class III 13(19.7%) patients. The commonest clinical presentation was nephrotic syndrome 33(50%) followed by chronic kidney disease 16(24.4%) and asymptomatic urinary abnormality 8(12.1%). Diabetic retinopathy (DR) was present in 27(41%) cases. DR was significantly higher in the class I patients (p < 0.05). Specificity and positive predictive values of DR for DN were 0.83 and 0.81, respectively (sensitivity 0.61; negative predictive values 0.64). The Association of the duration of diabetes and the level of proteinuria with DN was statistically not significant (p > 0.05). Idiopathic MN (6) and Amyloidosis (2) were the most common isolated NDKD; whereas diffuse proliferative glomerulonephritis (DPGN) (7) was the commonest NDKD in mixed disease. Another common form of NDKD in mixed disease was Thrombotic Microangiopathy (2) and IgA nephropathy (2). NDKD was observed in 5(18.5%) cases in presence of DR. We noted biopsy-proven DN even in 14(35.9%) cases without DR, in 4(50%) cases with microalbuminuria and 14(38.9%) cases with a short duration of diabetes. Conclusion: Almost half (45%) of cases with atypical presentation have non-diabetic kidney disease (NDKD), though even among these cases with atypical presentation diabetic nephropathy (either alone or in mixed form) is commonly seen in 74.2% of cases. DN has been seen in a subset of cases without DR, with microalbuminuria, and with a short duration of diabetes. Clinical indicators were insensitive in distinguishing DN Vs NDKD. Hence, a kidney biopsy may be a potential tool for the accurate diagnosis of kidney disease.

19 March 2019 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
SSShivendra Singh
Shivendra Singh
PPPrem Shankar Patel
Prem Shankar Patel
PDProdip Kumar Doley
Prodip Kumar Doley
SSShiv Shankar Sharma
Shiv Shankar Sharma
MIMohd. Iqbal
Mohd. Iqbal
AKAlok Kumar
Alok Kumar

10 July 2024 in Cureus
Verified
Journal Article
Open access
PDF file
PPPrem Shankar Patel
Prem Shankar Patel
PSPrit P. Singh
Prit P. Singh
AAArchana Archana
Archana Archana
OKOm Kumar
Om Kumar
Pigment-induced acute kidney injury (AKI) is an important and preventable complication of rhabdomyolysis or hemolysis. It is characterized by the release of free heme pigment (myoglobin or hemoglobin) in the circulation, leading to direct injury of the proximal tubule and distal tubule obstruction by pigment cast. We are reporting eight cases of pigment-induced AKI, including six cases of myoglobin cast nephropathy and two cases of hemoglobin cast nephropathy. The causes of rhabdomyolysis were strenuous exercise, infection/febrile illness, and drug-induced neuroleptic malignant syndrome. Paroxysmal nocturnal hemoglobinuria and anti-tuberculosis treatment (rifampicin and isoniazid) had led to hemoglobin cast nephropathy each in one case. Seven cases had severe renal failure requiring dialysis. Short-term renal outcome was favorable. However, long-term follow-up is necessary to determine whether pigment-induced AKI has delayed sequelae. Therefore, clinicians should consider rhabdomyolysis or hemolysis as potential hidden causes of AKI in diverse clinical conditions, especially those of non-traumatic origin, to achieve an accurate diagnosis.

1 January 2023 in Indian Journal of Nephrology
Verified
Journal Article
Open access
PPPrem Shankar Patel
Prem Shankar Patel
PSPritP Singh
PritP Singh
AKAmresh Krishna
Amresh Krishna
ARArchana
Archana
OKOm Kumar
Om Kumar

1 October 2023 in Indian Journal of Transplantation
Verified
Journal Article
Open access
PPPrem Shankar Patel
Prem Shankar Patel
AKAmresh Krishna
Amresh Krishna
PSPrit Pal Singh
Prit Pal Singh
SBShyam Bihari Bansal
Shyam Bihari Bansal
ARArchana
Archana
Immunocompromised host commonly develops a disseminated form of histoplasmosis and may have diverse manifestations. We present a case of histoplasmosis in a kidney transplant recipient who presented with pyrexia of unknown origin and pancytopenia. Bronchoalveolar lavage fluid analysis and serum antigen were negative for histoplasmosis. Bone marrow biopsy showed periodic acid–Schiff-positive intra and extracellular yeast-like organisms and later confirmed as Histoplasma capsulatum . The patient was successfully treated with intravenous liposomal amphotericin B, followed by oral itraconazole. Thus, bone marrow examination proved as key to diagnosis in our case.

5 June 2023 in Indian Journal of Nephrology
Verified
Journal Article
Open access
PPPrem Shankar Patel
Prem Shankar Patel
PSPrit P. Singh
Prit P. Singh
ARArchana
Archana
OKOm Kumar
Om Kumar
Myoglobin cast nephropathy is a sequel of rhabdomyolysis, and is characterized by the release of free myoglobin in the circulation, direct proximal convoluted tubule injury, and obstruction by myoglobin cast in distal tubules. We report an interesting case of myoglobin cast nephropathy in a patient who was on neuroleptic drugs and who presented with neuroleptic malignant syndrome and acute kidney injury.